Volume | 614,772 |
|
|||||
News | - | ||||||
Day High | 0.2194 | Low High |
|||||
Day Low | 0.2035 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Virios Therapeutics Inc | VIRI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.2171 | 0.2035 | 0.2194 | 0.2152 | 0.2072 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
875 | 614,772 | $ 0.2125306 | $ 130,658 | - | 0.1557 - 2.42 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:38 | 10 | $ 0.2182 | USD |
Virios Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.24M | 19.26M | - | 0 | -5.3M | -0.28 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Virios Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VIRI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.174 | 0.2429 | 0.1731 | 0.2221213 | 2,194,021 | 0.0443 | 25.46% |
1 Month | 0.4259 | 0.4609 | 0.1557 | 0.2246171 | 1,084,117 | -0.2076 | -48.74% |
3 Months | 0.3678 | 0.6288 | 0.1557 | 0.3181145 | 600,902 | -0.1495 | -40.65% |
6 Months | 0.57 | 0.94 | 0.1557 | 0.3795706 | 410,434 | -0.3517 | -61.70% |
1 Year | 1.61 | 2.42 | 0.1557 | 0.915617 | 496,261 | -1.39 | -86.44% |
3 Years | 5.31 | 9.1109 | 0.1557 | 0.9793661 | 515,836 | -5.09 | -95.89% |
5 Years | 13.76 | 14.39 | 0.1557 | 1.51 | 485,612 | -13.54 | -98.41% |
Virios Therapeutics Description
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. |